Health & Environmental Research Online (HERO)


Print Feedback Export to File
1047045 
Journal Article 
Validation of a screening method based on liquid chromatography coupled to high-resolution mass spectrometry for analysis of perfluoroalkylated substances in biota 
Berger, U; Haukås, M 
2005 
Yes 
Journal of Chromatography A
ISSN: 0021-9673
EISSN: 1873-3778 
1081 
210-217 
English 
A screening method for analysis of perfluoroalkylated substances (PFAS) in biota samples has been developed and validated using liver samples from polar cod (Boreogadus saida) and glaucous gull (Larus hyperboreus). The method was based on extraction of target compounds from homogenised samples into the solvent mixture used as mobile phase in high-performance liquid chromatography (HPLC), i.e. methanol/water (50:50; 2 mM ammonium acetate). The extract was filtered and directly injected into a HPLC/time-of-flight mass spectrometry (TOF-MS) system. Quantification was performed using 7H-perfluoroheptanoic acid as internal standard and a calibration standard solution dissolved in sample extract for each matrix type (matrix-matched calibration standard). The method is very time and cost efficient. Except for long-chain compounds and perfluorooctane sulfonamide (which cannot be covered by this method), recoveries were between 60% and 115% and method detection limits were in the range 0.04-1.3 ng/g wet weight. Blank values could be neglected with the exception of perfluorooctane sulfonate (PFOS), perfluorohexanoic acid (PFHxA) and perfluorooctanoic acid (PFOA). One of the major challenges in PFAS analysis is ionisation disturbance by co-eluting matrix in the ion source of the mass spectrometer. Both matrix and analyte specific signal enhancement and suppression was observed and quantified. Repeated extractions (n = 3) gave relative standard deviations (RSD) <35% for all PFAS. Accuracy was examined by comparing the screening method to the generally applied ion pair extraction (IPE) method. PFAS concentration values of a glaucous gull liver sample deviated by less than 30% for the two methods, provided that matrix-matched calibration standards were employed in both methods. 
perfluoroalkylated substances; perfluorooctane sulfonate; PFOS; high-resolution MS; method validation; screening method; liver samples 
PFAS
• Additional PFAS (formerly XAgency)
• Expanded PFAS SEM (formerly PFAS 430)
     Litsearch: September 2019
          PubMed
          Web of Science
     Not prioritized for screening
     7H-Perfluoroheptanoic acid
     Perfluorooctane
• ^Per- and Polyfluoroalkyl Substances (PFAS)
     PFHpA (375-85-9)
          Literature Search
               Pubmed
               WOS
     PFHxA (307-24-4)
          Literature Search
               Pubmed
               WOS
     PFOSA (754-91-6)
          Literature Search
               WOS
• PFAS 150
     Literature Search Update December 2020
          PubMed
          WOS
     Literature Search August 2019
          PubMed
          Web of Science
     Not prioritized for screening
     Ammonium perfluorooctanoate
     Perfluoroheptanoic acid
     Perfluorohexanoic acid
     Perfluorooctane
     Perfluorooctanesulfonic acid
     Perfluorooctanoic acid
     1,1,1,3,3,3-Hexafluoro-2- (fluoromethoxy)propane
• PFBA
     Protocol References
• PFHpA
     Literature Search
          Pubmed
          WOS
     Screening Results
          Excluded/Not on Topic
• PFHxA
     Literature Search
          Pubmed
          WOS
     Literature Search
          Pubmed
          WOS
     Scopus: April 2021
     Screening Results
          Excluded/Not on Topic
     Title and Abstract Screening
          Excluded
               Not relevant to PECO
     HAWC
• PFOSA
     Literature Search
          Pubmed
          WOS
     Screening Results
          Excluded/Not on Topic
• Yale PFAS Liver study